Global Infectious Disease Biomarker Testing Market Growth (Status and Outlook) 2021-2026

Global Infectious Disease Biomarker Testing Market Growth (Status and Outlook) 2021-2026

According to this latest study, the 2021 growth of Infectious Disease Biomarker Testing will have significant change from previous year. By the most conservative estimates of global Infectious Disease Biomarker Testing market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Infectious Disease Biomarker Testing market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Disease Biomarker Testing market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
PCR
NGS
ELISA or EIA
IHC
ISH
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hospitals and Clinics
Diagnostic Centers
Academic Research Institutes
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Abacus Diagnostica
ALPCO
Abbott Laboratories
Agilent Technologies
Becton
Dickinson and Company
bioMérieux SA
Bio-Rad Laboratories
Danaher
F. Hoffmann-La Roche
Hologic
PerkinElmer
Qiagen
Quest Diagnostics Incorporated
Siemens Healthineers
Thermo Fisher Scientific

Please note: The report will take approximately 2 business days to prepare and deliver.


*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Infectious Disease Biomarker Testing Market Size 2016-2026
2.1.2 Infectious Disease Biomarker Testing Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Infectious Disease Biomarker Testing Segment by Type
2.2.1 PCR
2.2.2 PCR
2.2.3 ELISA or EIA
2.2.4 IHC
2.2.5 ISH
2.2.6 Others
2.3 Infectious Disease Biomarker Testing Market Size by Type
2.3.1 Global Infectious Disease Biomarker Testing Market Size CAGR by Type
2.3.2 Global Infectious Disease Biomarker Testing Market Size Market Share by Type (2016-2021)
2.4 Infectious Disease Biomarker Testing Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Diagnostic Centers
2.4.3 Academic Research Institutes
2.4.4 Others
2.5 Infectious Disease Biomarker Testing Market Size by Application
2.5.1 Global Infectious Disease Biomarker Testing Market Size CAGR by Application
2.5.2 Global Infectious Disease Biomarker Testing Market Size Market Share by Application (2016-2021)
3 Infectious Disease Biomarker Testing Market Size by Players
3.1 Infectious Disease Biomarker Testing Market Size Market Share by Players
3.1.1 Global Infectious Disease Biomarker Testing Revenue by Players (2019-2021E)
3.1.2 Global Infectious Disease Biomarker Testing Revenue Market Share by Players (2019-2021E)
3.2 Global Infectious Disease Biomarker Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Infectious Disease Biomarker Testing by Regions
4.1 Infectious Disease Biomarker Testing Market Size by Regions (2016-2021)
4.2 Americas Infectious Disease Biomarker Testing Market Size Growth (2016-2021)
4.3 APAC Infectious Disease Biomarker Testing Market Size Growth (2016-2021)
4.4 Europe Infectious Disease Biomarker Testing Market Size Growth (2016-2021)
4.5 Middle East & Africa Infectious Disease Biomarker Testing Market Size Growth (2016-2021)
5 Americas
5.1 Americas Infectious Disease Biomarker Testing Market Size by Country (2016-2021)
5.2 Americas Infectious Disease Biomarker Testing Market Size by Type (2016-2021)
5.3 Americas Infectious Disease Biomarker Testing Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Disease Biomarker Testing Market Size by Region (2016-2021)
6.2 APAC Infectious Disease Biomarker Testing Market Size by Type (2016-2021)
6.3 APAC Infectious Disease Biomarker Testing Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Infectious Disease Biomarker Testing by Country (2016-2021)
7.2 Europe Infectious Disease Biomarker Testing Market Size by Type (2016-2021)
7.3 Europe Infectious Disease Biomarker Testing Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Infectious Disease Biomarker Testing by Region (2016-2021)
8.2 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Type (2016-2021)
8.3 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Infectious Disease Biomarker Testing Market Forecast
10.1 Global Infectious Disease Biomarker Testing Forecast by Regions (2021-2026)
10.1.1 Global Infectious Disease Biomarker Testing Forecast by Regions (2021-2026)
10.1.2 Americas Infectious Disease Biomarker Testing Forecast
10.1.3 APAC Infectious Disease Biomarker Testing Forecast
10.1.4 Europe Infectious Disease Biomarker Testing Forecast
10.1.5 Middle East & Africa Infectious Disease Biomarker Testing Forecast
10.2 Americas Infectious Disease Biomarker Testing Forecast by Countries (2021-2026)
10.2.1 United States Infectious Disease Biomarker Testing Market Forecast
10.2.2 Canada Infectious Disease Biomarker Testing Market Forecast
10.2.3 Mexico Infectious Disease Biomarker Testing Market Forecast
10.2.4 Brazil Infectious Disease Biomarker Testing Market Forecast
10.3 APAC Infectious Disease Biomarker Testing Forecast by Region (2021-2026)
10.3.1 China Infectious Disease Biomarker Testing Market Forecast
10.3.2 Japan Infectious Disease Biomarker Testing Market Forecast
10.3.3 Korea Infectious Disease Biomarker Testing Market Forecast
10.3.4 Southeast Asia Infectious Disease Biomarker Testing Market Forecast
10.3.5 India Infectious Disease Biomarker Testing Market Forecast
10.3.6 Australia Infectious Disease Biomarker Testing Market Forecast
10.4 Europe Infectious Disease Biomarker Testing Forecast by Country (2021-2026)
10.4.1 Germany Infectious Disease Biomarker Testing Market Forecast
10.4.2 France Infectious Disease Biomarker Testing Market Forecast
10.4.3 UK Infectious Disease Biomarker Testing Market Forecast
10.4.4 Italy Infectious Disease Biomarker Testing Market Forecast
10.4.5 Russia Infectious Disease Biomarker Testing Market Forecast
10.5 Middle East & Africa Infectious Disease Biomarker Testing Forecast by Region (2021-2026)
10.5.1 Egypt Infectious Disease Biomarker Testing Market Forecast
10.5.2 South Africa Infectious Disease Biomarker Testing Market Forecast
10.5.3 Israel Infectious Disease Biomarker Testing Market Forecast
10.5.4 Turkey Infectious Disease Biomarker Testing Market Forecast
10.5.5 GCC Countries Infectious Disease Biomarker Testing Market Forecast
10.6 Global Infectious Disease Biomarker Testing Forecast by Type (2021-2026)
10.7 Global Infectious Disease Biomarker Testing Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 Abacus Diagnostica
11.1.1 Abacus Diagnostica Company Information
11.1.2 Abacus Diagnostica Infectious Disease Biomarker Testing Product Offered
11.1.3 Abacus Diagnostica Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Abacus Diagnostica Main Business Overview
11.1.5 Abacus Diagnostica Latest Developments
11.2 ALPCO
11.2.1 ALPCO Company Information
11.2.2 ALPCO Infectious Disease Biomarker Testing Product Offered
11.2.3 ALPCO Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 ALPCO Main Business Overview
11.2.5 ALPCO Latest Developments
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Information
11.3.2 Abbott Laboratories Infectious Disease Biomarker Testing Product Offered
11.3.3 Abbott Laboratories Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Abbott Laboratories Main Business Overview
11.3.5 Abbott Laboratories Latest Developments
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Information
11.4.2 Agilent Technologies Infectious Disease Biomarker Testing Product Offered
11.4.3 Agilent Technologies Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Agilent Technologies Main Business Overview
11.4.5 Agilent Technologies Latest Developments
11.5 Becton
11.5.1 Becton Company Information
11.5.2 Becton Infectious Disease Biomarker Testing Product Offered
11.5.3 Becton Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Becton Main Business Overview
11.5.5 Becton Latest Developments
11.6 Dickinson and Company
11.6.1 Dickinson and Company Company Information
11.6.2 Dickinson and Company Infectious Disease Biomarker Testing Product Offered
11.6.3 Dickinson and Company Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Dickinson and Company Main Business Overview
11.6.5 Dickinson and Company Latest Developments
11.7 bioMérieux SA
11.7.1 bioMérieux SA Company Information
11.7.2 bioMérieux SA Infectious Disease Biomarker Testing Product Offered
11.7.3 bioMérieux SA Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 bioMérieux SA Main Business Overview
11.7.5 bioMérieux SA Latest Developments
11.8 Bio-Rad Laboratories
11.8.1 Bio-Rad Laboratories Company Information
11.8.2 Bio-Rad Laboratories Infectious Disease Biomarker Testing Product Offered
11.8.3 Bio-Rad Laboratories Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Bio-Rad Laboratories Main Business Overview
11.8.5 Bio-Rad Laboratories Latest Developments
11.9 Danaher
11.9.1 Danaher Company Information
11.9.2 Danaher Infectious Disease Biomarker Testing Product Offered
11.9.3 Danaher Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Danaher Main Business Overview
11.9.5 Danaher Latest Developments
11.10 F. Hoffmann-La Roche
11.10.1 F. Hoffmann-La Roche Company Information
11.10.2 F. Hoffmann-La Roche Infectious Disease Biomarker Testing Product Offered
11.10.3 F. Hoffmann-La Roche Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 F. Hoffmann-La Roche Main Business Overview
11.10.5 F. Hoffmann-La Roche Latest Developments
11. Hologic
11.11.1 Hologic Company Information
11.11.2 Hologic Infectious Disease Biomarker Testing Product Offered
11.11.3 Hologic Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Hologic Main Business Overview
11.11.5 Hologic Latest Developments
11.12 PerkinElmer
11.12.1 PerkinElmer Company Information
11.12.2 PerkinElmer Infectious Disease Biomarker Testing Product Offered
11.12.3 PerkinElmer Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 PerkinElmer Main Business Overview
11.12.5 PerkinElmer Latest Developments
11.13 Qiagen
11.13.1 Qiagen Company Information
11.13.2 Qiagen Infectious Disease Biomarker Testing Product Offered
11.13.3 Qiagen Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Qiagen Main Business Overview
11.13.5 Qiagen Latest Developments
11.14 Quest Diagnostics Incorporated
11.14.1 Quest Diagnostics Incorporated Company Information
11.14.2 Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Product Offered
11.14.3 Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Quest Diagnostics Incorporated Main Business Overview
11.14.5 Quest Diagnostics Incorporated Latest Developments
11.15 Siemens Healthineers
11.15.1 Siemens Healthineers Company Information
11.15.2 Siemens Healthineers Infectious Disease Biomarker Testing Product Offered
11.15.3 Siemens Healthineers Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 Siemens Healthineers Main Business Overview
11.15.5 Siemens Healthineers Latest Developments
11.16 Thermo Fisher Scientific
11.16.1 Thermo Fisher Scientific Company Information
11.16.2 Thermo Fisher Scientific Infectious Disease Biomarker Testing Product Offered
11.16.3 Thermo Fisher Scientific Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.16.4 Thermo Fisher Scientific Main Business Overview
11.16.5 Thermo Fisher Scientific Latest Developments
12 Research Findings and Conclusion

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook